N,N-dimethyl-1,2,3,4-tetrahydro-1,6-naphthyridin-5-amine, 95.0%, 500mg

Monohidrato de ácido gálico, mínimo 99%, 50 g, envase de plástico.

1,8-Diazaspiro[4.5]decan-2-one hydrochloride, 95.0%, 250mg

(S)-4-Nitrophenyl 2-(((benzyloxy)carbonyl)amino)-4-methylpentanoate, 95.0%, 1g

2-Methyl-6-(trifluoromethyl)benzyl bromide, 95.0%, 1g

4-[4-(trifluoromethyl)benzoyl]-1-oxa-4-azaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

3-(Benzyloxy)-N-methoxy-N-methylbenzamide, 97.0%, 250mg

5,7-Dichlorobenzo[d]thiazol-2-amine, 95.0%, 5g

2-Amino-4-chloro-5H-pyrrolo[3,2-d]pyrimidine, 97.0%, 1g

3-(1-Cyanoethyl)benzoic acid, 95.0%, 1kg

3-(2,2,2-Trifluoroacetyl)benzoic acid, 95%, 100mg

tert-Butyl (3,5-difluoropyridin-4-yl)carbamate, 95.0%, 1g

4-Chloro-3-methoxyaniline>98.0%(GC)(T)1g